CIK 0001842952
- Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 863738787
- Phone
- +1 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 13,000 shares at $3.22 ($41,850)
- 4/A Open-market buy Chief Executive Officer bought 10,000 shares at $5.00 ($50,000)
- 4/A Conversion SVP of R&D acquired 26,587 shares (conversion)
- 3/A Insider 3/A
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Legal Officer, Corp. Sec bought 3,000 shares at $5.00 ($15,000)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $5.00 ($50,000)
- 4 Conversion SVP of R&D acquired 26,587 shares (conversion)
- 3 Insider Initial Statement of Ownership
Page 4 of 5 · 88 filings